Foresite Capital, a healthcare and life sciences investment firm, has named Nick Smith as head of investor relations. Previously, Smith opened Winton Group‘s San Francisco office and data center.
San Francisco, CA — December 11, 2018 — Foresite Capital, a multi-stage healthcare and life sciences investment firm, today announced the appointment of Nick Smith as head of investor relations. Nick will lead Foresite Capital’s investor relations team, assuming responsibility for deepening relationships with the firm’s existing and prospective limited partners. Nick will be based in San Francisco.
Before joining Foresite Capital, Smith opened Winton Group’s San Francisco office and data science center, where he served the company as director and regional head of client advisory. In addition to servicing Winton’s clients and prospective clients, Nick was responsible for broad business development, including strategic collaborations within the technology and venture capital communities. Previously, Nick led marketing and investor relations for Northgate Capital, a global venture capital and private equity firm, and served as an executive of a boutique broker dealer based in San Francisco. Nick also founded Sagewood Capital, a registered commodity trading advisor.
“The innovation and transformation occurring in healthcare is generating a steady stream of compelling, institutional-quality investment opportunities, and I believe that Foresite Capital is well-positioned to capitalize on these trends as they continue,” said Smith. “I am thrilled to join Foresite Capital and help the firm continue to grow in a manner that is consistent with its values and unique, multi-stage investment approach.”
Smith’s professional experience also includes working for two California statewide elected officials. He served as Senior Advisor to the Director of Administration and Secretary of Foreign Affairs within the Office of the Governor and as Deputy State Controller in the Office of the California State Controller. While working in the state’s capitol, Nick served on the Selection Committee of the Executive Fellows program, which provided exceptional students an opportunity to work in various executive branch department and agencies. He is currently a member of the Sonoma County Community Foundation’s Investment Advisory Committee.
Smith joins a team of investment professionals at Foresite Capital, which closed its fourth and largest fund, the $668M Fund IV, in March of 2018. With Fund IV, the firm has increased its investment focus on companies applying the tools of data science to biological data.
“The Foresite Capital team comprises experts in a variety of disciplines, who work collaboratively to identify, fund and support our portfolio companies,” said Dennis Ryan, CFO of Foresite Capital. “We’re pleased to strengthen the team with the addition of Nick. He brings a wealth of experience and networks to the company.”
About Foresite Capital
Foresite Capital is a multi-stage healthcare and life sciences investment firm with $2 billion in assets under management. The firm seeks to address areas of great unmet medical need by funding and supporting transformative healthcare businesses. Foresite Capital has a uniquely collaborative investment model that benefits from insights generated by its multidisciplinary team of scientists, clinicians, investment analysts and engineers. It applies a rigorous scientific and data-driven approach to investment analysis. Foresite Capital understands the unique business models in healthcare and works closely with the firm’s portfolio companies at all stages of their lifecycle. The firm has offices in San Francisco and New York. For more information, please visit www.foresitecapital.com.
PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.
Take your pick!
- Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
- VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.